Navigation Links
Richard A. Schatz, M.D. Joins Cardium's Scientific Advisory Board
Date:5/1/2008

SAN DIEGO, May 1 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) announced today that Richard A. Schatz, M.D., has joined its Scientific Advisory Board. Dr. Schatz is an early pioneer of coronary stent technology and is best known for the co-development of the first successful coronary stent, the Palmaz-Schatz stent. Dr. Schatz is Research Director of Cardiovascular Interventions at the Heart, Lung, and Vascular Center at Scripps Clinic in La Jolla, California. He is also active in gene and stem cell therapy research and teaches and lectures worldwide.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

"We are very pleased to have Richard Schatz join our scientific advisory board," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium. "Richard is not only a pioneer in the development of vascular stents but has been involved in landmark studies related to new therapies for treating cardiovascular disease. We look forward to benefiting from his expert insights and years of experience in the field of interventional cardiology as we move forward in the development of our lead product candidate, Generx, for the potential treatment of recurrent angina associated with coronary heart disease."

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications. Cardium's lead product candidate, Generx(TM) (alferminogene tadenovec, Ad5FGF4), is a DNA-based growth factor therapeutic being developed for potential use by interventional cardiologists as a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ische
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
2. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
3. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
5. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
6. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
7. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
8. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
9. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
10. Hank Plain Joins Morgenthaler Ventures as Partner
11. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...l/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY...updated results from a Phase II study of intraveno...c to the lung in a poster presentation at the 15th... held in Miami Beach, Florida, from November 5th t...II Study of Intravenous REOLYSIN (Wild-type Reovir...
(Date:11/5/2009)... , Fuel economy ratings for the new 2010 model y...nomy.gov web site, which Oak Ridge National Labor...ent of Energy and the U.S. Environmental Protectio...fuel economy list are hybrid electrics, led by the...t proves that hybrids have gone mainstream," said ...
(Date:11/5/2009).../ -- DSM Pharmaceutical Products today announced t...nix, Saint Jean D,Illac, France, where DSM will be...ner for Galenix commercial products on a global ba...iness development opportunities co-marketing Galen...th of Galenix in drug product development and clin...
(Date:11/5/2009)...r 5, 2009 at 4:30 p.m. Eastern Time , BOTHELL... OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or t...dited financial results for the third quarter and ...the Company,s highlights for the third quarter of ...lect the operations of OncoGenex Technologies Inc....
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...stem cell research to high-tech bicycles to an ide...Tommy Thomspson, Wisconsin Technology Network read...es they clicked on and read during the last three ...test edition of Wisconsin Technology Review ­...logy Network. , ,As in past reviews, we present t...
...ICAGO -- The summer of 2005 has come and gone and...summer. I just spent an incredible weekend enjoyin... in my hometown of Scarsdale (just outside of New ...asy at this reunion (no, its not what you think!)....ear (1969-1970), we had this phenomenal rock and b...
...son, Wis. - Companies that register for the Oct. ... seminar that will help them prepare to seek priva... level. , ,"Venture Readiness Tools for Commercia...within the larger conference at Madison ,s Monona ...or the full symposium may take part in the 8:30 a....
Other Biology Technology:Midwest large cap life science group strengthening in the third quarter 2Midwest large cap life science group strengthening in the third quarter 3Early Stage Symposium session will help emerging companies prepare for investors 2
(Date:11/4/2009)...Mass., Oct. 20 Aware, In...nd technology and biometrics software, today repor... September 30, 2009. ,, Michael Tzannes, Awar...arlier today, we announced an agreement to sell ou... a new fabless semiconductor company being spun ou...
(Date:11/4/2009)... Calif., Oct. 23 GenVault Corporat...anagement for genomic discovery, medicine and iden...D., GenVault,s President and CEO, will be presenti...on October 26th and 27th in La Jolla, CA. ,, Du...overview of the company together with recent custo...
(Date:11/4/2009)... Oct. 27 Global Rainmakers, Inc., ...ced R&D laboratory, today announced that the c...ed to actively commercialize its suite of technolo...ecurity offerings. ,, During the past four year...rs to develop and deploy a series of core--but exp...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 1Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 2Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 3Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 4Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 1Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 2Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 3Got a Problem 3F Think About It Overnight 48276 1Got a Problem 3F Think About It Overnight 48276 2
...om researchers at Harvard Medical School and Massa...osed at the 13th European Cancer Conference (ECCO)...delivery is possible using nanoparticle-apatamer c... aptamers) are short DNA or RNA fragments that can... affinity; analogous to monoclonal antibodies. In ...
...existence to tiny microorganisms living in the oce... vital services these microbes perform for the pla...sed today by the American Academy of Microbiology,...arth,s Habitability. , "Since life most likely beg...osest living descendants of the original forms of ...
...t -- a single light box and the over-the-counter d... by resetting their circadian body clock before cr...ch being published in The Endocrine Society,s Jour...s treatment can also help those with delayed sleep...t results from a misalignment between a person,s i...
Other Biology News:Researchers use 'trickery' to create immune response against melanoma 2Researchers use 'trickery' to create immune response against melanoma 3Researchers use 'trickery' to create immune response against melanoma 4Understanding the oceans microbes is key to the Earth's future 2Travelers can avoid jet lag by resetting their body clocks 2Travelers can avoid jet lag by resetting their body clocks 3
...onoclonal [198C679.2.1] to Presenilin 2 Alzheimer... the disease carry mutations in the presenilin pro...ein (APP). These disease-linked mutations result i...id-beta (main component of amyloid deposits found ...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: